Prostate Cancer Screening: Who to test, when to investigate and when to refer (Clinical lunch chat on-demand)
In this Clinical Lunch Chat, Dr Rust Theron and Dr David Smart discuss a practical, evidence-based approach to prostate cancer screening in primary care.
Learning outcomes
- Identify men who may benefit from prostate cancer screening based on age, family history, ancestry, genetic risk and life expectancy
- Apply shared decision-making when discussing the benefits, limitations and potential harms of PSA screening
- Interpret PSA results in the context of clinical findings, potential confounding factors and individual risk
- Recognise the role and limitations of DRE, repeat PSA testing and prostate MRI in early detection
- Determine when an abnormal PSA, suspicious clinical findings or other risk factors warrant urological referral
- Distinguish between screening asymptomatic men and investigating patients with symptoms or findings suggestive of prostate cancer.
To access this module, please register or login: